News for VolitionRx Limited (VNRX)

PR NewswireHENDERSON, Nev., July 16, 2025 HENDERSON, Nev., July 16, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-na

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

PR NewswireHENDERSON, Nev., May 19, 2025 Clinical Paper Published in BMC Veterinary ResearchHENDERSON, Nev., May 19, 2025 /PRNewswire/ -- VolitionRx Limite

First successful detection of nucleosomes in cats, expanding Nu.Q® technology to a third species. Large market opportunity with over 60

May 16, 2025 / 12:30PM GMTOperator Good morning ladies and gentlemen. Thank you for standing by. Welcome to VolitionRX Ltd Limited's first quarter 2025 earnings

Key Takeaways: VolitionRX Ltd (VNRX) shows promising revenue growth with a notable 44% increase year-over-year. The average analyst price target suggests

VolitionRX Limited (NYSE:VNRX) Q1 2025 Earnings Conference Call May 16, 2025 8:30 AM ETCompany ParticipantsLouise Batchelor – Chief Marketing and...

PR NewswireHENDERSON, Nev., May 15, 2025 Conference call to discuss financial and operational results scheduled for Friday, May 16 at 8:30 a.m. U.S. Easter

VolitionRx (VNRX) reported a 44% increase in revenue year-over-year to $0.25 million in Q1 2025. Monthly cash burn decreased by 50% to $1.4 million from

PR NewswireHenderson, Nev., May 12, 2025 Conference call to take place on Friday, May 16 at 8:30 a.m. U.S Eastern TimeHenderson, Nev., May 12, 2025 /PRNews

VolitionRx Limited (VNRX) to host Q1 2025 earnings call and business update on May 16, 2025. The call will cover financial and operational results, rece

PR NewswireHENDERSON, Nev., April 29, 2025 HENDERSON, Nev., April 29, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-n

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

Operator: Good afternoon ladies and gentlemen and thank you for standing by. Welcome to VolitionRx Limited Fourth Quarter and Full Fiscal Year 2024 Earnings Conference Call.

VolitionRx Limited (NYSE:VNRX) Q4 2024 Earnings Conference Call March 31, 2025 4:30 PM ETCompany ParticipantsLouise Batchelor - Chief Marketing &...

PR NewswireHENDERSON, Nev., March 28, 2025 Studies demonstrate how Volition's Nu.Q®H3K27Me3 biomarker, when combined with ctDNA, may improve the prognosti

PR NewswireHENDERSON, Nev., March 21, 2025 Volition study shows rapid, low-cost, automated Nu.Q® Cancer test accurately detects human cancers at high spec

PR NewswireHENDERSON, Nev., March 20, 2025 "Lung Cancer: Hope of a Brighter Tomorrow" illustrates how Nu.Q® Cancer Test aims to transform the diagnosis,

PR NewswireHENDERSON, Nev., March 17, 2025 Volition to host multiple presentations at the International Symposium on Intensive Care & Emergency Medicine in